BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ulven T, Little PB, Receveur J, Frimurer TM, Rist Ø, Nørregaard PK, Högberg T. 6-Acylamino-2-amino-4-methylquinolines as potent melanin-concentrating hormone 1 receptor antagonists: Structure–activity exploration of eastern and western parts. Bioorganic & Medicinal Chemistry Letters 2006;16:1070-5. [DOI: 10.1016/j.bmcl.2005.10.066] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Witty DR, Bateson JH, Hervieu GJ, Jeffrey P, Johnson CN, Muir AI, O’hanlon PJ, Stemp G, Stevens AJ, Thewlis KM, Wilson S, Winborn KY. SAR of biphenyl carboxamide ligands of the human melanin-concentrating hormone receptor 1 (MCH R1): Discovery of antagonist SB-568849. Bioorganic & Medicinal Chemistry Letters 2006;16:4865-71. [DOI: 10.1016/j.bmcl.2006.06.056] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
2 Wu M, Li Y, Fu X, Wang J, Zhang S, Yang L. Profiling the interaction mechanism of quinoline/quinazoline derivatives as MCHR1 antagonists: an in silico method. Int J Mol Sci 2014;15:15475-502. [PMID: 25257526 DOI: 10.3390/ijms150915475] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
3 Wu L, Wang Y, Song H, Tang L, Zhou Z, Tang C. Synthesis of Optically Active 2 H -Thiopyrano[2,3- b ]quinolines with Three Contiguous Stereocenters via an Organocatalytic Asymmetric Tandem Michael-Henry Reaction. Adv Synth Catal 2013;355:1053-7. [DOI: 10.1002/adsc.201300086] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 6.1] [Reference Citation Analysis]
4 Jiang J, Lin P, Hoang M, Chang L, Tan C, Feighner S, Palyha OC, Hreniuk DL, Pan J, Sailer AW, Morin NR, Macneil DJ, Howard AD, Van der Ploeg LH, Goulet MT, Devita RJ. 4-Aminoquinoline melanin-concentrating hormone 1-receptor (MCH1R) antagonists. Bioorganic & Medicinal Chemistry Letters 2006;16:5275-9. [DOI: 10.1016/j.bmcl.2006.08.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
5 Giordanetto F, Karlsson O, Lindberg J, Larsson LO, Linusson A, Evertsson E, Morgan DG, Inghardt T. Discovery of cyclopentane- and cyclohexane-trans-1,3-diamines as potent melanin-concentrating hormone receptor 1 antagonists. Bioorg Med Chem Lett 2007;17:4232-41. [PMID: 17532215 DOI: 10.1016/j.bmcl.2007.05.034] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
6 Jiang Y, Chen C, Lu K, Daniewska I, De Leon J, Kong R, Forray C, Li B, Hegde LG, Wolinsky TD, Craig DA, Wetzel JM, Andersen K, Marzabadi MR. Synthesis and SAR Investigations for Novel Melanin-Concentrating Hormone 1 Receptor (MCH 1 ) Antagonists Part 1. The Discovery of Arylacetamides as Viable Replacements for the Dihydropyrimidinone Moiety of an HTS Hit. J Med Chem 2007;50:3870-82. [DOI: 10.1021/jm060381c] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
7 Sasmal PK, Sasmal S, Rao PT, Venkatesham B, Roshaiah M, Abbineni C, Khanna I, Jadhav VP, Suresh J, Talwar R, Muzeeb S, Receveur J, Frimurer TM, Rist Ø, Elster L, Högberg T. Discovery of novel, orally available benzimidazoles as melanin concentrating hormone receptor 1 (MCHR1) antagonists. Bioorganic & Medicinal Chemistry Letters 2010;20:5443-8. [DOI: 10.1016/j.bmcl.2010.07.086] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
8 Méndez-Andino JL, Colson AO, Meyers KM, Mitchell MC, Hodge K, Howard JM, Kim N, Ackley DC, Holbert JK, Mittelstadt SW, Dowty ME, Obringer CM, Suchanek P, Reizes O, Hu XE, Wos JA. The efficacy and cardiac evaluation of aminomethyl tetrahydronaphthalene ketopiperazines: a novel class of potent MCH-R1 antagonists. Bioorg Med Chem 2007;15:2092-105. [PMID: 17236777 DOI: 10.1016/j.bmc.2006.12.028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
9 Khidre RE, Radini IAM, Ibrahim DA. Synthetic Approaches of Pyrazolyl Quinolines. MROC 2019;16:353-60. [DOI: 10.2174/1570193x15666180419142511] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
10 Blakeney JS, Reid RC, Le GT, Fairlie DP. Nonpeptidic Ligands for Peptide-Activated G Protein-Coupled Receptors. Chem Rev 2007;107:2960-3041. [DOI: 10.1021/cr050984g] [Cited by in Crossref: 74] [Cited by in F6Publishing: 65] [Article Influence: 4.9] [Reference Citation Analysis]
11 Sasmal S, Balaji G, Kanna Reddy HR, Balasubrahmanyam D, Srinivas G, Kyasa S, Sasmal PK, Khanna I, Talwar R, Suresh J, Jadhav VP, Muzeeb S, Shashikumar D, Harinder Reddy K, Sebastian VJ, Frimurer TM, Rist Ø, Elster L, Högberg T. Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists. Bioorg Med Chem Lett 2012;22:3157-62. [PMID: 22487182 DOI: 10.1016/j.bmcl.2012.03.050] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
12 Meyers KM, Kim N, Méndez-andino JL, Hu XE, Mumin RN, Klopfenstein SR, Wos JA, Mitchell MC, Paris JL, Ackley DC, Holbert JK, Mittelstadt SW, Reizes O. Aminomethyl tetrahydronaphthalene biphenyl carboxamide MCH-R1 antagonists—Increasing selectivity over hERG. Bioorganic & Medicinal Chemistry Letters 2007;17:814-8. [DOI: 10.1016/j.bmcl.2006.10.053] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
13 Högberg T, Frimurer TM, Sasmal PK. Melanin concentrating hormone receptor 1 (MCHR1) antagonists—Still a viable approach for obesity treatment? Bioorganic & Medicinal Chemistry Letters 2012;22:6039-47. [DOI: 10.1016/j.bmcl.2012.08.025] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
14 Meyers KM, Méndez-andino J, Colson A, Hu XE, Wos JA, Mitchell MC, Hodge K, Howard J, Paris JL, Dowty ME, Obringer CM, Reizes O. Novel pyrazolopiperazinone- and pyrrolopiperazinone-based MCH-R1 antagonists. Bioorganic & Medicinal Chemistry Letters 2007;17:657-61. [DOI: 10.1016/j.bmcl.2006.10.096] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
15 Wang Y, Chang M, Zhang H, Li Y. Convenient synthesis of 12-methyl[1]benzoxepino[3,4-b]quinolin-13(6H)-ones. Chem Heterocycl Comp 2018;54:650-7. [DOI: 10.1007/s10593-018-2322-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Schwan WR, Dunek C, Gebhardt M, Engelbrecht K, Klett T, Monte A, Toce J, Rott M, Volk TJ, LiPuma JJ, Liu XT, McKelvey R. Screening a mushroom extract library for activity against Acinetobacter baumannii and Burkholderia cepacia and the identification of a compound with anti-Burkholderia activity. Ann Clin Microbiol Antimicrob 2010;9:4. [PMID: 20092635 DOI: 10.1186/1476-0711-9-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
17 Mekheimer RA, Al-sheikh MA, Medrasi HY, Sadek KU. Advancements in the synthesis of fused tetracyclic quinoline derivatives. RSC Adv 2020;10:19867-935. [DOI: 10.1039/d0ra02786c] [Cited by in Crossref: 9] [Article Influence: 4.5] [Reference Citation Analysis]
18 Rokosz LL. Discovery and development of melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity. Expert Opinion on Drug Discovery 2007;2:1301-27. [DOI: 10.1517/17460441.2.10.1301] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
19 Kumar SV, Muthusubramanian S, Perumal S. Facile “on water” domino reactions for the expedient synthesis of 2H-thiopyrano[2,3-b]quinolines. RSC Adv 2015;5:30826-32. [DOI: 10.1039/c5ra04795a] [Cited by in Crossref: 12] [Article Influence: 1.7] [Reference Citation Analysis]
20 Chen C, Jiang Y, Lu K, Daniewska I, Mazza CG, Negron L, Forray C, Parola T, Li B, Hegde LG, Wolinsky TD, Craig DA, Kong R, Wetzel JM, Andersen K, Marzabadi MR. Synthesis and SAR Investigations for Novel Melanin-Concentrating Hormone 1 Receptor (MCH 1 ) Antagonists Part 2:  A Hybrid Strategy Combining Key Fragments of HTS Hits. J Med Chem 2007;50:3883-90. [DOI: 10.1021/jm060383x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
21 Luthin DR. Anti-obesity effects of small molecule melanin-concentrating hormone receptor 1 (MCHR1) antagonists. Life Sci 2007;81:423-40. [PMID: 17655875 DOI: 10.1016/j.lfs.2007.05.029] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 4.3] [Reference Citation Analysis]
22 Jiang J, Hoang M, Young JR, Chaung D, Eid R, Turner C, Lin P, Tong X, Wang J, Tan C, Feighner S, Palyha O, Hreniuk DL, Pan J, Sailer AW, Macneil DJ, Howard A, Shearman L, Stribling S, Camacho R, Strack A, Van der Ploeg LH, Goulet MT, Devita RJ. 2-Aminoquinoline melanin-concentrating hormone (MCH)1R antagonists. Bioorganic & Medicinal Chemistry Letters 2006;16:5270-4. [DOI: 10.1016/j.bmcl.2006.08.006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
23 Cavasotto CN, Orry AJ, Murgolo NJ, Czarniecki MF, Kocsi SA, Hawes BE, O'Neill KA, Hine H, Burton MS, Voigt JH, Abagyan RA, Bayne ML, Monsma FJ Jr. Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening. J Med Chem 2008;51:581-8. [PMID: 18198821 DOI: 10.1021/jm070759m] [Cited by in Crossref: 123] [Cited by in F6Publishing: 118] [Article Influence: 8.8] [Reference Citation Analysis]
24 Mekheimer RA, Ahmed EA, Sadek KU. Recent developments in the chemistry of pyrazolo[4,3-c]quinolines. Tetrahedron 2012;68:1637-67. [DOI: 10.1016/j.tet.2011.10.088] [Cited by in Crossref: 32] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
25 Arienzo R, Cramp S, Dyke HJ, Lockey PM, Norman D, Roach AG, Smith P, Wong M, Wren SP. Quinazoline and benzimidazole MCH-1R antagonists. Bioorganic & Medicinal Chemistry Letters 2007;17:1403-7. [DOI: 10.1016/j.bmcl.2006.11.092] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
26 Meyers KM, Méndez-andino JL, Colson A, Warshakoon NC, Wos JA, Mitchell MC, Hodge KM, Howard JM, Ackley DC, Holbert JK, Mittelstadt SW, Dowty ME, Obringer CM, Reizes O, Hu XE. Aminomethyl tetrahydronaphthalene ketopiperazine MCH-R1 antagonists—Increasing selectivity over hERG. Bioorganic & Medicinal Chemistry Letters 2007;17:819-22. [DOI: 10.1016/j.bmcl.2006.10.052] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]